Serum Institute seeks EUA for its Covovax vaccine for 12-17 years age group
NEW DELHI: Serum Institute of India (SII) has sought emergency use authorisation from India's drug regulator for its COVID-19 vaccine...
NEW DELHI: Serum Institute of India (SII) has sought emergency use authorisation from India's drug regulator for its COVID-19 vaccine...
NEW DELHI: Serum Institute of India (SII) -- the world's largest vaccine maker -- on Friday said it has resumed...
NEW DELHI: Minister of State for Ports, Shipping & Waterways (I/C) and Minister of State for Chemicals & Fertilizers Mansukh...
WASHINGTON: Novavax's COVID-19 jab is more than 90 percent effective, including against coronavirus variants, the vaccine maker said Monday after...
NEW YORK: WHO chief Tedros Adhanom Ghebreyesus has said that once the devastating COVID-19 outbreak in India recedes, the Serum...
LONDON: The Serum Institute of India (SII) will invest GBP 240 million in the UK to expand its vaccine business...
NEW DELHI: The Serum Institute of India (SII), which manufactures the AstraZeneca coronavirus (Covid-19) vaccine, is planning to start vaccine...
NEW DELHI: World Bank President David Malpass has said that with the Serum Institute, India is blessed to have a...